GQ-16

GQ-16 Struktur
870554-67-9
CAS-Nr.
870554-67-9
Englisch Name:
GQ-16
Synonyma:
GQ-16;GQ-16 Exclusive;5Z-[(5-bromo-2-methoxyphenyl)methylene]-3-[(4-methylphenyl)methyl]-2,4-thiazolidinedione;2,4-Thiazolidinedione, 5-[(5-bromo-2-methoxyphenyl)methylene]-3-[(4-methylphenyl)methyl]-, (5Z)-;(5Z)-5-[(5-bromo-2-methoxyphenyl)methylidene]-3-[(4-methylphenyl)methyl]-1,3-thiazolidine-2,4-dione;PPAR,Inhibitor,reduced adipogenic actions,PPARγ,GQ-16,insulin sensitization,inhibit,Peroxisome proliferator-activated receptors,insulin Resistance,GQ16,GQ 16
CBNumber:
CB63152621
Summenformel:
C19H16BrNO3S
Molgewicht:
418.3
MOL-Datei:
870554-67-9.mol

GQ-16 Eigenschaften

Schmelzpunkt:
147 °C
Siedepunkt:
549.8±60.0 °C(Predicted)
Dichte
1.522±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
≤0.33mg/ml in DMSO;5mg/ml in dimethyl formamide
Aggregatzustand
crystalline solid
pka
-2.57±0.20(Predicted)
Farbe
Off-white to light yellow

Sicherheit

GQ-16 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Full activation of peroxisome proliferator-activated receptor γ (PPARγ), e.g., using thiazolidinediones, effectively treats insulin resistance and type 2 diabetes but also commonly promotes weight gain, hyperphagia, and edema. GQ-16 is a partial agonist for PPARγ (Ki = 160 nM) which induces adipogenesis significantly less than the full activator rosiglitazone. Like rosiglitazone, GQ-16 reverses high fat diet-mediated impairments in insulin signaling. However, GQ-16 does not induce weight gain, hyperphagia, or edema. GQ-16 does not activate PPARα, PPARβ/δ, or RXRα.

GQ-16 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


GQ-16 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 37)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43348 58
BOC Sciences 16314854226
info@bocsci.com United States 9926 65
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9707 58
MQ (shanghai) Pharmaceuticals Co., Ltd. 13761635123
1014988033@qq.com China 4992 55
Yujinpharma(Tianjin) Technology Co.,Ltd. 13370351217 kungfu1217@1
kungfu1217@163.com China 9384 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
sales@chemegen.com China 11289 58
MedBioPharmaceutical Technology Inc 021-69568360 18916172912
order@med-bio.cn China 8141 58
Jinan Jiuli Biotechnology Co. , Ltd. 14768611851
486064515@qq.com China 2277 58
Bide Pharmatech Ltd. 400-1647117 15221909166
product02@bidepharm.com China 63720 58
Henan Alpha Chemical Co., Ltd. 0371-55013243 15324716602
2853979810@qq.com China 10010 58

  • GQ-16
  • 5Z-[(5-bromo-2-methoxyphenyl)methylene]-3-[(4-methylphenyl)methyl]-2,4-thiazolidinedione
  • (5Z)-5-[(5-bromo-2-methoxyphenyl)methylidene]-3-[(4-methylphenyl)methyl]-1,3-thiazolidine-2,4-dione
  • GQ-16 Exclusive
  • PPAR,Inhibitor,reduced adipogenic actions,PPARγ,GQ-16,insulin sensitization,inhibit,Peroxisome proliferator-activated receptors,insulin Resistance,GQ16,GQ 16
  • 2,4-Thiazolidinedione, 5-[(5-bromo-2-methoxyphenyl)methylene]-3-[(4-methylphenyl)methyl]-, (5Z)-
  • 870554-67-9
Copyright 2019 © ChemicalBook. All rights reserved